CUT&RUN as a Powerful Tool for Chromatin Profiling: a Focus on Neuropsychiatric Disorders

Neuropsychiatric disorders like addiction and depression are fundamentally linked to maladaptive neuroplasticity, which is driven by lasting changes in gene expression. These changes are controlled by a complex regulatory system involving transcription factors (TFs) and epigenetic modifications—such as histone post-translational modifications (hPTMs)—that govern chromatin structure and DNA accessibility. Traditionally, researchers relied on Chromatin Immunoprecipitation sequencing (ChIP-seq) to study these interactions. However, ChIP-seq often requires large amounts of tissue and is hindered by high background noise and artifacts introduced by cross-linking and sonication, making it difficult to investigate specific brain regions or rare cell types.

Cleavage Under Targets and Release Using Nuclease (CUT&RUN) has emerged as a powerful, more efficient alternative to ChIP-seq. The technique uses antibodies to target specific chromatin-bound proteins, after which a micrococcal nuclease (MNase) is tethered to the target site via protein A/G fusion to selectively cleave the DNA. Because this occurs within intact nuclei, it avoids the harsh lysis and fragmentation steps associated with ChIP-seq. This process results in a much higher signal-to-noise ratio, enabling researchers to perform high-resolution profiling with significantly lower tissue input—fewer than 10,000 cells compared to the millions required for traditional ChIP.

CUT&RUN has already provided novel insights into neuropsychiatric conditions by allowing for studies that were previously technically impossible. For example, it has been used to identify "chromatin scars" (like H3K27me1 enrichment) that mediate stress susceptibility and to map the genome-wide binding dynamics of ΔFOSB in specific neurons following cocaine exposure. By integrating these high-resolution datasets with other multi-omics approaches, such as RNA-seq or ATAC-seq, researchers can now build a comprehensive picture of how specific epigenetic states prime neurons for altered gene expression in response to drug use or environmental stress. As the field moves from purely descriptive studies toward mechanistic interventions like epigenome editing, the precision of CUT&RUN is essential for identifying actionable therapeutic targets.